Oric Pharmaceuticals (ORIC) Capital Expenditures (2019 - 2026)
Oric Pharmaceuticals (ORIC) posted Capital Expenditures of $2000.0 for Q1 2026, down 99.12% on a QoQ basis from $227000.0 in Q4 2025, and down 99.48% year-over-year from $387000.0 in Q1 2025.
Oric Pharmaceuticals (ORIC) Capital Expenditures (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals' Capital Expenditures history runs 8 years deep, the most recent figure standing at $2000.0 for Q1 2026.
- Quarterly Capital Expenditures fell 99.48% year-over-year to $2000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $327000.0 (down 75.9% YoY) and the FY2025 annual result came in at $712000.0, down 40.07% from the prior year.
- Capital Expenditures was $2000.0 for Q1 2026 at Oric Pharmaceuticals, down from $227000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $723000.0 in Q1 2022 and bottomed at $2000.0 in Q1 2026.
- A 5-year average of $284058.8 and a median of $287000.0 in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2024 — Capital Expenditures jumped 442.86% — and 2026, when it sank 99.48%.
- Oric Pharmaceuticals' Capital Expenditures stood at $287000.0 in 2022, then tumbled by 80.14% to $57000.0 in 2023, then jumped by 284.21% to $219000.0 in 2024, then rose by 3.65% to $227000.0 in 2025, then slumped by 99.12% to $2000.0 in 2026.
- Business Quant data shows ORIC's Capital Expenditures at $2000.0 in Q1 2026, $227000.0 in Q4 2025, and $35000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Oric Pharmaceuticals | 1.15 Bn | 866.67 Mn | - | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 227,000.00 |
| Dec 31, 2025 | 227,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Mar 31, 2025 | 387,000.00 |
| Mar 31, 2025 | 387,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Sep 30, 2024 | 418,000.00 |
| Sep 30, 2024 | 418,000.00 |
| Jun 30, 2024 | 333,000.00 |
| Jun 30, 2024 | 333,000.00 |
| Mar 31, 2024 | 218,000.00 |
| Mar 31, 2024 | 218,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Dec 31, 2023 | 57,000.00 |